Study the Levels of Total Enzymatic Antioxidants in Patients with Hydatid Cysts

Subject Areas : Journal of Chemical Health Risks

Shaimaa Raheem Hussein ¹ (The Almutafawiqat students` school, The general Directorate of Education, Najaf, Iraq)
Hayder Ali Mindeel Neama <sup>2</sup> (The Almutafawiqat students` school, The general Directorate of Education, Najaf, Iraq)

Received: 2021-07-30 Accepted : 2021-11-27 Published : 2021-10-01

Keywords:

References:

1. Wahlers K., Menezes C.N., Wong M.L., Zeyhle E., 2012. Cystic echinococcosis in sub-Saharan Africa. The Lan. Infect. Dis. 12, 871-880.


2. Ersayit D., Kilic E., Yazar S., Artı T., 2009. Oxidative Stres in Patients with Cystic Echninococcosis: Relationship Between Oxidant and Antioxidant Parameters. Erciyes University. J Health Sci. 18, 159-166.


3. Filippou D., Tselepis D., Filippou G., Papadopoulos V., 2007. Advance in liver echinococcosis: Diagnosis and treatment. Clin. Gastroenterol. Hepatol. 5(2), 152-159


4. Afonso V., Champy R., Mitrovic D., Collin P., Lomri A., 2007. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine. 74, 324-329.


5. Fattman C.L., Schaefer L.M., Oury T.D., 2003. Extracellular superoxide dismutase in biology and Medicine. Free Radic. Biol Med. 35, 236-256.


6. Lawi Z.K.K., Merza F.A. , Banoon S.R., Al-Saady M.A., Al-Abbood A., 2021. Mechanisms of Antioxidant Actions and their Role in many Human Diseases: A Review. Journal of Chemical Health Risks.11, 45-57.


7. Bertrand K.E., Mathieu N., Inocent G., Honore F.K., 2008. Antioxidant status of bilirubin and uric acid in patients diagnosed with Plasmodium falciparum malaria in Douala. Pak J Biol Sci. 11,1646-1649.


8. Apak R., Gu¨clu¨ K., O¨ zyu¨rek M., Celik S.E., 2008. Mechanism of antioxidant capacity assays and the CUPRAC [cupric ion reducing antioxidant capacity] assay. Microchim Acta. 160(4), 413–419


9. Falih I.Q., Alobeady M.A., Banoon S.R., Saleh M.Y., 2021. Role of Oxidized Low-density Lipoprotein in Human Diseases: A Review. Journal of Chemical Health Risks.11, 71-83.


10. Morgan G.A., Leech N.A., Gloecner G.W., Barrett K.C., 2010. SPSS for introductory statistic: use and interpretation. 2^nd ed. Lawrence Erlbum associates, publisers Mahwah, New Jersey, London.


11. Al-Mukhtar A., Qasim I.K., 2017. Serological Survey of Hydatid Disease in Asymptomatic Peoples in Mosul City, Iraq. Raf J Sci. 26(1), 1-8.


12. Saida L.A., Nouraddin A.S., 2011. Epidemiological study of cystic echinococcosis in Man and slaughtered Animals in Erbil province, Kurdistan Regional-Iraq. Tikrit J Pure Sci. 16(4), 45-50.


13. Mohammed M.O., 2013. The Human Seroprevalence of Echinococcus Granulosus in Sulaimani Governorate. The Iraqi Postgraduate Medical J. 12(1), 45-50.


14. Awatif A.A., 1999. Epidemiology of hydatid disease in Riyadh: a Hospial –based study. Annals Saudi Medicine. 19(5), 450-452


15. Shahrokhabadi R., Rahimi E., Poursahebi R., 2013. Seroepidemiological study of human hydatidosis in Rafsanjan, Kerman. Zahedan J Res Med Sci. 15, 50.16.


16. Yilmaz M., Mert H., Irak K., 2018. The Effect of Fucoidan on the Gentamicin Induced Ne-phrotoxicity in Rats. Fresen Envıron Bull. 27(4), 2235-41.


17. Halliwel B., 1990. How to charecterize a biological antioxidant. Free Radic Res Commun. 1,1-32


18. Irak K., Çelik A.B., Karakoc Z., Çelik Y.Ö., Mert N., Mert K.M., 2018. Oxidant/Antioxidant Status, PON1 and ARES Activities, Trace Element Levels, and Histological Alterations in Sheep with Cystic Echinococcosis Iran. J Paras. 13(3), 448-456.


19. Amanvermez R., 1997. The effectiveness of oxidants [roi, rni] in Echinococcus granulosus hydatid cysts and an investigation of their antioxidant systems. Ph.D.Thesis University of Ondokuz Mayıs, Samsun, Turkey.


20. Halliwell B., 1994. Free radicals antioxidants, human disease: curiosity cause or consequence. Lancet. 344(8924), 721-4.